|
TBC1D12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.558300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.723700E-03 |
| Normal-vs-Stage2 |
2.478200E-01 |
| Normal-vs-Stage3 |
6.966000E-01 |
| Normal-vs-Stage4 |
8.081200E-01 |
| Stage1-vs-Stage2 |
7.338200E-01 |
| Stage1-vs-Stage3 |
2.009500E-02 |
| Stage1-vs-Stage4 |
4.697600E-03 |
| Stage2-vs-Stage3 |
3.765600E-01 |
| Stage2-vs-Stage4 |
2.060200E-01 |
| Stage3-vs-Stage4 |
5.595800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.833600E-02 |
| Normal-vs-AfricanAmerican |
4.057000E-01 |
| Normal-vs-Asian |
8.645800E-02 |
| Caucasian-vs-AfricanAmerican |
5.857000E-01 |
| Caucasian-vs-Asian |
3.997900E-02 |
| AfricanAmerican-vs-Asian |
1.752090E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.374200E-02 |
| Normal-vs-Female |
1.372990E-01 |
| Male-vs-Female |
5.621200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.669000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.724000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.830000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.834800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.494790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.338400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.210400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.763900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.118500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.051800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.612700E-04 |
| Normal-vs-Grade 2 |
2.559900E-03 |
| Normal-vs-Grade 3 |
1.214030E-01 |
| Normal-vs-Grade 4 |
2.993900E-02 |
| Grade 1-vs-Grade 2 |
2.166200E-01 |
| Grade 1-vs-Grade 3 |
2.195900E-02 |
| Grade 1-vs-Grade 4 |
3.8429000000062E-05 |
| Grade 2-vs-Grade 3 |
7.010300E-02 |
| Grade 2-vs-Grade 4 |
4.00330000038807E-07 |
| Grade 3-vs-Grade 4 |
3.562900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.972700E-04 |
| Normal-vs-ccB subtype |
3.408800E-01 |
| ccA subtype-vs-ccB subtype |
1.559540E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.353500E-02 |
| Normal-vs-N1 |
8.094400E-01 |
| N0-vs-N1 |
7.128400E-01 |
|
|
